While RIG-I activation with synthetic RNA has been shown to enhance NK cell-mediated killing of melanoma cells [30,33], exposure of NK cells to IAV, a RIG-I stimulating virus, has been reported to reduce NK cell cytotoxicity [29,34]. The gene discussed is RIGI; the disease is melanoma.